Dual-targeting biomimetic delivery for anti-glioma activity<i>via</i>remodeling the tumor microenvironment and directing macrophage-mediated immunotherapyPengfei Zhao, Yongzhuo Huang|Chemical Science|2018Cited by 248
Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable deliveryHongyue Jin, Yongzhuo Huang|Theranostics|2018Cited by 212
Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codeliveryZening Zheng, Yongzhuo Huang|Journal for ImmunoTherapy of Cancer|2020Cited by 134
Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapyXuejia Kang, Yongzhuo Huang|Acta Pharmacologica Sinica|2017Cited by 111
Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted deliveryLong Li, Yongzhuo Huang|Journal of Experimental & Clinical Cancer Research|2023Cited by 70